Welcome to
Allurion’s
Newsroom

Filter by language : AR / DE / EN / ES / FR / IT / NL
October 8, 2019

Allurion expands in Natick, raises $60M

WORCESTER BUSINESS JOURNAL – The privately held company has raised $60 million in capital, with its largest investor Romulus Capital in Boston, Gaur said. Friday’s ribbon cutting at its new facility doubled as Allurion’s 10th anniversary, and Gaur used the occasion to look both back and ahead. “In the next 10 years,” Gaur said, “we’ll ask, how can we have (customers) with us for not just four years but for decades?” With U.S. Food and Drug Administration approval expected next year and a market debut in late 2020, Gaur thinks the company can hit the 200,000-a-year figure in the next four or five years.

October 8, 2019

Allurion Technologies’ Elipse® Program Demonstrates Significant Weight Loss in Findings Presented at 24th World IFSO Congress

BUSINESS WIRE – Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced results from three key abstracts presented at the 24th World IFSO Congress. The abstracts examine the Elipse Program — featuring the Elipse Balloon, the world’s first and only procedureless medical device for weight loss — and show significant decreases in both weight and cardiovascular disease markers, such as LDL cholesterol and hemoglobin A1c, in patients who have used the balloon for weight loss.

October 8, 2019

Un ballon intra-gastrique pour lutter contre l’obésité

IMAZ PRESS – “Ce dispositif provisoire permet au patient en surpoids ou obèse de prendre de bonnes habitudes alimentaires au travers d’une éducation, notamment sur la nature, les quantités et la vitesse de l’alimentation […]. De ce fait, le ballon, en raison de son fonctionnement par satiété aide le patient à atteindre les objectifs attendus” note la clinique.

September 20, 2019

Allurion Technologies’ Elipse® Program Demonstrates Significant Weight Loss in Findings Presented at 24th World IFSO Congress

Three oral presentations, including a Top 10 abstract, highlight the efficacy and safety of the Elipse Balloon, the world’s first and only procedureless™ gastric balloon. Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced results from three key abstracts presented at the 24th World IFSO Congress. The abstracts examine the Elipse Program—featuring the Elipse Balloon, the world’s first and only procedureless medical device for weight loss—and show significant decreases in both weight and cardiovascular disease markers, such as LDL cholesterol and hemoglobin A1c, in patients who have used the balloon for weight loss.

September 20, 2019

Allurion expands in Natick, raises $60M

The privately held company has raised $60 million in capital, with its largest investor Romulus Capital in Boston, Gaur said. Friday’s ribbon cutting at its new facility doubled as Allurion’s 10th anniversary, and Gaur used the occasion to look both back and ahead. “In the next 10 years,” Gaur said, “we’ll ask, how can we have (customers) with us for not just four years but for decades?” With U.S. Food and Drug Administration approval expected next year and a market debut in late 2020, Gaur thinks the company can hit the 200,000-a-year figure in the next four or five years.

September 16, 2019

Natick’s Allurion Technologies marks a milestone

Allurion Technologies, maker of the world’s only gastric balloon for weight loss that doesn’t involve surgert, is shooting to become a $0 billion company, according to co-founder Dr. Shantanu Gaur. More than 15,000 (Elipse Balloons) have sold in the past three years – all in Europe and the Middle East. A clinical trial of 400 participants ended, and Gaur said his company will send results to the FDA shortly. He hopes U.S. sales start late next year.

September 11, 2019

Weight loss balloon DOES help you shed pounds faster, three new studies find

The single-dose treatment, called Elipse, could help “potentially millions” of obese people blitz as much as three stone, experts said. The first of the three new studies looking at the effectiveness of the weight loss balloon examined 1,623 patients across seven different countries who had tried it. And Allurion’s Chief Medical Officer Dr Ram Chuttani said: “These presentations underscore the impact the Elipse Programme can have on overweight and obese individuals treated by a variety of practitioners in different clinical settings all over the world.

September 11, 2019

Weight loss balloon DOES help you shed pounds faster, three new studies find

THE SUN – The single-dose treatment, called Elipse, could help “potentially millions” of obese people blitz as much as three stone, experts said. The first of the three new studies looking at the effectiveness of the weight loss balloon examined 1,623 patients across seven different countries who had tried it. And Allurion’s Chief Medical Officer Dr Ram Chuttani said: “These presentations underscore the impact the Elipse Programme can have on overweight and obese individuals treated by a variety of practitioners in different clinical settings all over the world.

August 21, 2019

Non-surgical gastric balloon launches into aesthetics market

AESTHETICS JOURNAL – Dr Gaur said, “I have seen the success that this product has had in weight management clinics specifically, however I see the potential for Elipse to be transformative in the aesthetics industry because there are so many aesthetic interventions that just are not affective unless you have lost some of the visceral fat from your abdomen. The training is straightforward and there is no endoscopy, no surgery and no anaesthesia required. So it’s something very scalable”

August 19, 2019

Mum who binged after son was born drops 3 dress sizes after swallowing a balloon

THE SUNDAY MIRROR – “I don’t have the balloon inside me anymore, but the new routine it’s set up is here to stay. I used to be a very anxious, negative person, but now I feel so confident and empowered. It’s changed my body and my mind, and I’ll never go back to how I was before.” Valeria Rebeque de Brityo, 42, from Surrey, had the Elipse last November.